- Report
- July 2026
- 105 Pages
Global
From €4446EUR$4,750USD£3,716GBP
- Report
- July 2026
- 131 Pages
Global
From €4446EUR$4,750USD£3,716GBP
- Report
- January 2026
- 120 Pages
Global
From €4446EUR$4,750USD£3,716GBP
- Report
- January 2026
- 120 Pages
Global
From €4446EUR$4,750USD£3,716GBP
- Report
- August 2026
- 115 Pages
Global
From €4446EUR$4,750USD£3,716GBP
- Report
- August 2026
- 108 Pages
Global
From €4446EUR$4,750USD£3,716GBP
- Report
- August 2026
- 119 Pages
Global
From €4446EUR$4,750USD£3,716GBP
- Report
- July 2026
- 114 Pages
Global
From €4446EUR$4,750USD£3,716GBP
- Report
- July 2026
- 180 Pages
Global
From €4446EUR$4,750USD£3,716GBP
- Report
- July 2026
- 185 Pages
Global
From €4446EUR$4,750USD£3,716GBP
- Report
- April 2026
- 104 Pages
Global
From €4446EUR$4,750USD£3,716GBP
- Report
- July 2026
- 200 Pages
Global
From €7478EUR$7,990USD£6,251GBP
- Report
- July 2026
- 399 Pages
Global
From €7478EUR$7,990USD£6,251GBP
- Report
- January 2026
- 220 Pages
Global
From €3276EUR$3,500USD£2,738GBP
- Report
- July 2026
- 150 Pages
Global
From €3510EUR$3,750USD£2,934GBP
- Report
- May 2026
- 150 Pages
Global
From €3510EUR$3,750USD£2,934GBP
- Report
- January 2026
- 550 Pages
Global
From €4680EUR$5,000USD£3,912GBP
- Report
- January 2026
- 280 Pages
Global
From €2808EUR$3,000USD£2,347GBP
- Report
- May 2026
- 350 Pages
Global
From €4632EUR$4,949USD£3,872GBP
- Report
- May 2026
- 350 Pages
Global
From €4632EUR$4,949USD£3,872GBP

The Genetic Disease market is a subset of the Genomics market that focuses on the diagnosis, treatment, and prevention of genetic diseases. It is a rapidly growing field, driven by advances in technology and the increasing availability of genetic testing. Companies in this market are developing new treatments and therapies for genetic diseases, as well as diagnostic tests and tools to identify and monitor them. They are also researching ways to prevent genetic diseases from occurring in the first place.
Companies in the Genetic Disease market include Illumina, Thermo Fisher Scientific, BGI, Genomic Health, and Invitae. These companies are developing innovative products and services to help diagnose, treat, and prevent genetic diseases. They are also investing in research and development to further advance the field. Show Less Read more